Inotuzumab ozogamicin
About
Therapy type: Targeted therapy
Therapy strategy: BCR-ABL inhibition
Mappings
NCI Thesaurus: Inotuzumab Ozogamicin (ncit:C71542)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy.| Type | Biomarker(s) | Cancer type | Therapy(ies) | |
|---|---|---|---|---|
| Sensitivity (+) | CD22 + | Acute Lymphoid Leukemia | Inotuzumab ozogamicin | |
| Sensitivity (+) | CD22 + | Acute Lymphoid Leukemia | Inotuzumab ozogamicin | |
| Sensitivity (+) | BCR::ABL1, CD22 + | Acute Lymphoid Leukemia | Inotuzumab ozogamicin | |
| Sensitivity (+) | CD22 + | Acute Lymphoid Leukemia | Inotuzumab ozogamicin | |
| Sensitivity (+) | BCR::ABL1, CD22 + | Acute Lymphoid Leukemia | Inotuzumab ozogamicin |